2025 |
Adaptive Biotechnologies Corp
|
Independent Director |
- |
- |
2024 |
Adaptive Biotechnologies Corp
|
Independent Director |
310 K |
0.0 % |
2023 |
Adaptive Biotechnologies Corp
|
Independent Director |
310.0 K |
4.6 % |
2023 |
Singular Genomics Systems Inc
|
- |
131.5 K |
-22.2 % |
2023 |
GeneDx Holdings Corp - Warrants (22/07/2026)
|
Independent Director |
- |
- |
2022 |
Adaptive Biotechnologies Corp
|
Independent Director |
296.3 K |
1.7 % |
2022 |
GeneDx Holdings Corp - Warrants (22/07/2026)
|
Independent Director |
252.8 K |
- |
2022 |
GeneDx Holdings Corp - Ordinary Shares - Class A
|
- |
252.8 K |
-40.1 % |
2022 |
Singular Genomics Systems Inc
|
Lead Independent Director |
169.0 K |
-56.1 % |
2021 |
GeneDx Holdings Corp - Ordinary Shares - Class A
|
Independent Director |
421.9 K |
- |
2021 |
Singular Genomics Systems Inc
|
Lead Independent Director |
384.6 K |
- |
2021 |
Adaptive Biotechnologies Corp
|
Independent Director |
291.3 K |
38.7 % |
2020 |
Adaptive Biotechnologies Corp
|
Independent Director |
210.0 K |
136.2 % |
2020 |
Singular Genomics Systems Inc
|
Lead Independent Director |
- |
- |
2020 |
GeneDx Holdings Corp - Ordinary Shares - Class A
|
Independent Director |
- |
- |
2019 |
Adaptive Biotechnologies Corp
|
Independent Director |
88.9 K |
-85.8 % |
2018 |
Adaptive Biotechnologies Corp
|
Independent Director |
626.3 K |
- |